Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms.

  title={Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms.},
  author={Martin Begemann and Sabrina Grube and Sergi Papiol and D{\"o}rthe Malzahn and Henning Krampe and Katja Ribbe and Heidi Friedrichs and Konstantin A Radyushkin and Ahmed El-Kordi and Fritz Benseler and Kathrin Hannke and Swetlana Sperling and Dayana Schwerdtfeger and Ivonne Thanh{\"a}user and Martin Fungisai Gerchen and Mohammad Ghorbani and Stefan Gutwinski and Constanze Hilmes and Richard Leppert and Anja Ronnenberg and Julia Friederike Sowislo and Sabina Stawicki and Maren St{\"o}dtke and Christoph Johannes Szuszies and Kerstin Reim and Joachim Riggert and Fritz Eckstein and Peter Falkai and Heike Bickeboeller and Klaus-Armin Nave and Nils Brose and Hannelore Ehrenreich},
  journal={Archives of general psychiatry},
  volume={67 9},
CONTEXT Schizophrenia is the collective term for a heterogeneous group of mental disorders with a still obscure biological basis. In particular, the specific contribution of risk or candidate gene variants to the complex schizophrenic phenotype is largely unknown. OBJECTIVE To prepare the ground for a novel "phenomics" approach, a unique schizophrenia patient database was established by GRAS (Göttingen Research Association for Schizophrenia), designed to allow association of genetic… CONTINUE READING